Private company
Semler Scientific, Inc.
American electromedical and electrotherapeutic apparatus company.
Last updated Oct 18, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024
37.2%Operating margin3
72.7%Net margin3
-17.4%Revenue growth, 20243
17.7%Return on equity3
$24.4MFree cash flow3
Where the money goes
Where each dollar of revenue went, fiscal 2024
- Cost of revenue8¢$4.8M
- Research and development8¢$4.8M
- Income tax12¢$7.0M
- Profit71¢$40.9M
Out of $56.3M in revenue.3
Where each dollar of operating cash went, fiscal 2024
- Capital spending0¢$51.0K
- Kept or used elsewhere100¢$24.4M
Out of $24.4M of cash from operations.3
Financial statements
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | $21.5M4 | $32.8M5 | $38.6M6 | $53.0M7 | $56.7M8 | $68.2M8 | $56.3M3 |
| Cost of revenue | $2.7M4 | $3.7M5 | $3.4M6 | $6.1M7 | $4.3M8 | $7.0M3 | $4.8M3 |
| Research and development | $4.4M8 | $5.8M3 | $4.8M3 | ||||
| Operating income | $5.3M4 | $10.7M5 | $16.0M6 | $19.4M7 | $17.2M8 | $22.3M3 | $20.9M3 |
| Interest | $59.0K12 | ||||||
| Income tax | $26.0K4 | -$4.4M5 | $2.5M6 | $2.2M7 | $3.4M8 | $3.5M3 | $7.0M3 |
| Net income | $5.0M4 | $15.1M5 | $14.0M6 | $17.2M7 | $14.3M8 | $20.6M3 | $40.9M3 |
| Earnings per share | $0.824 | $2.345 | $2.136 | $2.567 | $2.138 | $3.063 | $5.663 |
| Earnings per share (diluted) | $0.664 | $1.885 | $1.746 | $2.127 | $1.798 | $2.633 | $5.133 |
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Cash | $3.3M5 | $7.7M5 | $22.1M6 | $37.3M7 | $23.0M8 | $57.2M3 | $8.8M3 |
| Current assets | $6.2M4 | $11.4M5 | $26.6M6 | $45.5M7 | $48.9M8 | $65.9M3 | $22.7M3 |
| Total assets | $7.7M4 | $18.3M5 | $34.6M6 | $50.7M7 | $62.7M8 | $78.1M3 | $239.8M3 |
| Current liabilities | $3.5M4 | $5.2M5 | $4.5M6 | $4.9M7 | $6.9M8 | $6.2M3 | $6.3M3 |
| Long-term debt | $012 | ||||||
| Shareholders’ equity | $4.2M5 | $13.1M6 | $29.8M7 | $45.5M8 | $55.7M3 | $71.8M3 | $230.8M3 |
| Shares outstanding | 6.3M shares4 | 6.5M shares5 | 6.7M shares6 | 6.8M shares7 | 6.7M shares8 | 6.9M shares3 | 9.6M shares3 |
Leadership
Who has led Semler Scientific, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
201520202025
- Chief executive officerDouglas Murphy-Chutorian Feb 20, 2014 to now13
- PresidentRobert McRae Nov 12, 2014 to Jul 22, 201514
- Chief financial officerDouglas Murphy-Chutorian Nov 18, 2025 to now15
- Chief financial officerRenae Cormier Jul 13, 2023 to Nov 18, 202516
- Chief operating officerRobert McRae Feb 20, 2014 to Jul 22, 201517
Board members and other officers (16)
- Senior VP, Finance and Acct.Andrew B. Weinstein Oct 5, 2018 to Oct 5, 201818
- Vice President of FinanceDaniel E. Conger Feb 20, 2014 to May 12, 202019
- Board memberNatalie Brunell May 22, 2025 to now20
- Board memberEric Semler Apr 20, 2023 to now21
- Board memberDaniel S. Messina Aug 17, 2020 to now22
- Board memberCindy Moon Nov 12, 2020 to Feb 3, 202323
- Board memberDouglas Murphy-Chutorian Feb 20, 2014 to now13
- Board memberElliot A. Sainer Feb 20, 2014 to Feb 27, 201424
- Board memberGreg Shaw Garfield Feb 20, 2014 to Feb 22, 201625
- Board memberHerbert J. Semler Feb 20, 2014 to Sep 15, 201726
- Board memberShirley L. Semler Feb 20, 2014 to Sep 15, 201727
- Board memberWilliam H. Chang Feb 20, 2014 to now28
- Board memberBruce Barclay May 6, 2014 to Feb 22, 201629
- Board memberWayne T. Pan May 14, 2014 to Feb 3, 202330
- Board memberArthur N. Leibowitz Jun 26, 2014 to Feb 3, 202331
- Board memberAidan Matthew Collins Jul 8, 2014 to Feb 22, 201632
Timeline
Filings
289 filings to the SEC since October 2021: 4 annual reports, 13 quarterly reports, 74 major events, 78 insider forms, 35 large holders, 85 other. The latest 20:
- May 11, 2026SCHEDULE 13G/A EDGAR
- Feb 11, 2026SCHEDULE 13G EDGAR
- Jan 26, 202615-12G EDGAR
- Jan 21, 2026EFFECT EDGAR
- Jan 21, 2026EFFECT EDGAR
- Jan 16, 20268-K EDGAR
- Jan 16, 20264 OWNERSHIP DOCUMENT EDGAR
- Jan 16, 20264 OWNERSHIP DOCUMENT EDGAR
- Jan 16, 20264 OWNERSHIP DOCUMENT EDGAR
- Jan 16, 20264 OWNERSHIP DOCUMENT EDGAR
- Jan 16, 20264 OWNERSHIP DOCUMENT EDGAR
- Jan 16, 2026SCHEDULE 13D/A EDGAR
- Jan 16, 2026SCHEDULE 13D/A EDGAR
- Jan 16, 2026S-8 POS EDGAR
- Jan 16, 2026S-8 POS EDGAR
- Jan 16, 2026S-8 POS EDGAR
- Jan 16, 2026S-8 POS EDGAR
- Jan 16, 2026S-8 POS EDGAR
- Jan 16, 2026S-8 POS EDGAR
- Jan 16, 2026POS AM EDGAR
The 289 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 35 such filings since October 2021, the latest 10:
- May 11, 2026SCHEDULE 13G/A
- Feb 11, 2026SCHEDULE 13G
- Jan 16, 2026SCHEDULE 13D/A
- Jan 16, 2026SCHEDULE 13D/A
- Nov 14, 2025SCHEDULE 13G/A
- Nov 13, 2025SCHEDULE 13G/A
- Nov 13, 2025SCHEDULE 13G/A
- Oct 17, 2025SCHEDULE 13G
- Sep 17, 2025SCHEDULE 13G
- Aug 14, 2025SCHEDULE 13G
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARRobert McRae, President
- 15
- 16
- 17
- 18
- 19
- 20SEC EDGARNatalie Brunell, Board member
- 21SEC EDGAREric Semler, Board member
- 22SEC EDGARDaniel S. Messina, Board member
- 23SEC EDGARCindy Moon, Board member
- 24SEC EDGARElliot A. Sainer, Board member
- 25SEC EDGARGreg Shaw Garfield, Board member
- 26SEC EDGARHerbert J. Semler, Board member
- 27SEC EDGARShirley L. Semler, Board member
- 28SEC EDGARWilliam H. Chang, Board member
- 29SEC EDGARBruce Barclay, Board member
- 30SEC EDGARWayne T. Pan, Board member
- 31SEC EDGARArthur N. Leibowitz, Board member
- 32SEC EDGARAidan Matthew Collins, Board member
- 33